相关实验视频

Updated: Sep 9, 2025

Routine Screening Method for Microparticles in Platelet Transfusions

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

血小板受体激活剂对肌痛性综合征的血小板输血需求的影响:更新的系统综述和元分析

Nouman Aziz¹, Waseem Nabi¹, Hafiz Muhammad Umer²

¹Wyckoff Heights Medical Center, Brooklyn, NY.

Clinical lymphoma, myeloma & leukemia

|August 29, 2025

概括

血小板受体激活剂 (TPO-RAs) 有效地降低了肌肉发育综合征 (MDS) 患者的血小板输血. 这些治疗方法不会增加白血病进展或死亡的风险,提供支持性护理而不会改变疾病的进程.

科学领域:

血液学
癌症学
临床试验

背景情况:

骨髓分裂综合征 (MDS) 中的血小板减少导致出血和输血依赖性.
血小板输血是标准的, 但有免疫和感染风险等限制.
血栓形成素受体激活剂 (TPO-RAs) 是新兴的替代品,其有效性和安全性尚未完全确定.

研究的目的:

系统地审查和对MDS患者的TPO-RAs随机对照试验 (RCTs) 的元分析.
评估TPO-RA对血小板输血发生率和其他关键临床结果的影响.

主要方法:

对10项涉及908名成年MDS患者的RCT进行了系统审查和元分析.
在主要数据库 (PubMed,EMBASE,科学网,Cochrane CENTRAL,临床试验.gov) 进行搜索.
评估结果:血小板输血发生率,反应率,AML转变,出血,死亡率和存活率.

主要成果:

TPO- RA治疗显著降低了血小板输血发生率 (RR 0. 67;95% CI,0. 54- 0. 86).
在整体反应,AML转变,严重出血,血液状况改善,整体存活率或死亡率方面没有发现显著差异.
亚组分析显示,对eltrombopag和romiplostim的输血减少类似.

结论:

在MDS患者中,TPO-RA显著降低了血小板输血需求.
这些药物提供有效的支持性治疗,但不能改善存活率或改变疾病的进展.
对长期结果和组合疗法的进一步研究是有必要的.

关键词:

洗钱问题急性骨髓性白血病转变美国其他:血小板减少

更多相关视频

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Role of Hematopoietic Growth Factors

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...